NCT03339193View on ClinicalTrials.gov

Procedure RElated Outcomes With the Watchman FLX Left Atrial Appendage Closure Device

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Atrial FibrillationStroke
Interventions
DEVICE

Left atrial appendage closure

Percutaneous insertion of a Watchman FLX left atrial appendage closure device under general anesthesia with transesophageal echo guidance.

Trial Locations (1)

OX3 9DU

Department of Cardiology, John Radcliffe Hospital, Oxford

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Oxford University Hospitals NHS Trust

OTHER